Clinical and brain structural effects of the Illness Management and Recovery program in middle-aged and older patients with schizophrenia.
Ryota NakamuraTakeshi AsamiAsuka YoshimiDaiji KatoEmi FujitaMasao TakaishiHaruhisa YoshidaHiroyuki YamaguchiKazumasa ShiozakiAkihiko KaseYoshio HirayasuPublished in: Psychiatry and clinical neurosciences (2019)
This is the first report demonstrating the effectiveness of the IMR program for improving psychotic symptoms and psychosocial function and protecting brain structure in middle-aged and older inpatients with schizophrenia hospitalized for long periods.